Invesaro

Stocks Comparison

Hims & Hers Health vs Oncology Institute: revenue, profit, margins and growth compared

Hims & Hers Health brought in $2.3B of revenue in fiscal 2025, Oncology Institute $502.7M in fiscal 2025. Revenue changed by +59.0% at Hims & Hers Health and +27.8% at Oncology Institute on the year before, so Hims & Hers Health grew faster. Hims & Hers Health kept 5.5% of its revenue as net profit, Oncology Institute -12.1%. Free cash flow was $57.4M at Hims & Hers Health and -$27.8M at Oncology Institute.

Side by side, latest fiscal year

HIMSTOI
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$2.3B$502.7M
Revenue growth+59.0%+27.8%
Net income$128.4M-$60.6M
Net margin5.5%-12.1%
Free cash flow$57.4M-$27.8M
Free cash flow margin2.4%-5.5%
Earnings per share (diluted)$0.51-$0.54
Cash$228.6M$33.6M
Debtn/a$77.4M
Price to earnings56.4n/a
Market value$6.7B$522.8M
Dividend yieldn/an/a
Rank by revenue in sector#105 of 742 · Health care#204 of 742 · Health care

Over the years

Revenue
HIMS FY2019: $82.6MHIMS FY2020: $148.8MHIMS FY2021: $271.9MHIMS FY2022: $526.9MHIMS FY2023: $872MHIMS FY2024: $1.5BHIMS FY2025: $2.3BTOI FY2020: $187.5MTOI FY2021: $203MTOI FY2022: $252.5MTOI FY2023: $324.2MTOI FY2024: $393.4MTOI FY2025: $502.7MFY19FY20FY21FY22FY23FY24FY25
HIMS $2.3BTOI $502.7M
Net income
HIMS FY2019: -$72.1MHIMS FY2020: -$18.1MHIMS FY2021: -$107.7MHIMS FY2022: -$65.7MHIMS FY2023: -$23.5MHIMS FY2024: $126MHIMS FY2025: $128.4MTOI FY2020: -$14.3MTOI FY2021: -$10.9MTOI FY2022: $152KTOI FY2023: -$83.1MTOI FY2024: -$64.7MTOI FY2025: -$60.6MFY19FY20FY21FY22FY23FY24FY25
HIMS $128.4MTOI -$60.6M
Net margin
HIMS FY2019: -87.3%HIMS FY2020: -12.2%HIMS FY2021: -39.6%HIMS FY2022: -12.5%HIMS FY2023: -2.7%HIMS FY2024: 8.5%HIMS FY2025: 5.5%TOI FY2020: -7.6%TOI FY2021: -5.4%TOI FY2022: 0.1%TOI FY2023: -25.6%TOI FY2024: -16.4%TOI FY2025: -12.1%FY19FY20FY21FY22FY23FY24FY25
HIMS 5.5%TOI -12.1%
Revenue growth
HIMS FY2020: +80.2%HIMS FY2021: +82.8%HIMS FY2022: +93.8%HIMS FY2023: +65.5%HIMS FY2024: +69.3%HIMS FY2025: +59.0%TOI FY2021: +8.3%TOI FY2022: +24.4%TOI FY2023: +28.4%TOI FY2024: +21.3%TOI FY2025: +27.8%FY20FY21FY22FY23FY24FY25
HIMS +59.0%TOI +27.8%
Free cash flow
HIMS FY2022: -$33.7MHIMS FY2023: $47MHIMS FY2024: $198.3MHIMS FY2025: $57.4MTOI FY2020: -$686KTOI FY2021: -$35.5MTOI FY2022: -$67.3MTOI FY2023: -$40.9MTOI FY2024: -$30.3MTOI FY2025: -$27.8MFY20FY21FY22FY23FY24FY25
HIMS $57.4MTOI -$27.8M

Fiscal years as each company reports them; the two may end in different months.

Questions about Hims & Hers Health and Oncology Institute

Which is bigger by revenue, Hims & Hers Health or Oncology Institute?

Hims & Hers Health is bigger by revenue: $2.3B in fiscal 2025, against $502.7M for Oncology Institute in fiscal 2025.

Which keeps more of its revenue as profit, Hims & Hers Health or Oncology Institute?

Hims & Hers Health had a net margin of 5.5% in fiscal 2025; Oncology Institute had -12.1% in fiscal 2025.

Which grew revenue faster, Hims & Hers Health or Oncology Institute?

In their latest fiscal years revenue changed by +59.0% at Hims & Hers Health and +27.8% at Oncology Institute.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies